IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
IGM Biosciences, Inc. (IGMS)
Last igm biosciences, inc. earnings: 3/26 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
MOUNTAIN VIEW, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, and Mary Beth Harler, M.D., Head, Research & Autoimmunity, will participate in a fireside chat at the Stifel 2024 Virtual Immunology and Inflammation Summit on Tuesday, September 17, 2024, at 9:00 a.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investor.igmbio.com/news-and-events/events-and-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation. About IGM Biosciences, Inc.IGM Biosciences is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. IGM
Show less
Read more
Impact Snapshot
Event Time:
IGMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IGMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IGMS alerts
High impacting IGM Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
IGMS
News
- While shareholders of IGM Biosciences (NASDAQ:IGMS) are in the black over 1 year, those who bought a week ago aren't so fortunate [Yahoo! Finance]Yahoo! Finance
- IGM Biosciences (IGMS) Surges 11.6%: Is This an Indication of Further Gains? [Yahoo! Finance]Yahoo! Finance
- IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target lowered by analysts at HC Wainwright from $12.00 to $11.00. They now have a "neutral" rating on the stock.MarketBeat
- IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target lowered by analysts at Truist Financial Co. from $25.00 to $24.00. They now have a "buy" rating on the stock.MarketBeat
- IGM Biosciences, Inc. (NASDAQ: IGMS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $20.00 price target on the stock.MarketBeat
IGMS
Earnings
- 8/14/24 - Miss
IGMS
Sec Filings
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- IGMS's page on the SEC website